Literature DB >> 9450175

Drug delivery to the lymphatic system.

C J Porter1.   

Abstract

The specialized structure and function of the lymphatics has stimulated considerable interest in both site-specific drug delivery to the lymph and lymphoid tissue, and delivery to the systemic circulation via lymphatic transport mechanisms. In this review, drug access to the lymphatic system from the vasculature or interstitium after parenteral administration, and from the gastrointestinal tract after enteral administration, is discussed. Macromolecular and lipophilic prodrug approaches to lymphatic delivery and the use of microparticulate systems such as microspheres, liposomes, and colloidal carbon are also examined and discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9450175

Source DB:  PubMed          Journal:  Crit Rev Ther Drug Carrier Syst        ISSN: 0743-4863            Impact factor:   4.889


  13 in total

1.  Improved antifilarial activity of ivermectin in chitosan-alginate nanoparticles against human lymphatic filarial parasite, Brugia malayi.

Authors:  Mohammad Ali; Mohammad Afzal; Meenakshi Verma; Shailja Misra-Bhattacharya; Farhan Jalees Ahmad; Amit Kumar Dinda
Journal:  Parasitol Res       Date:  2013-07-05       Impact factor: 2.289

2.  S-Nitrosated Polypropylene Sulfide Nanoparticles for Thiol-Dependent Transnitrosation and Toxicity Against Adult Female Filarial Worms.

Authors:  Alex Schudel; Timothy Kassis; J Brandon Dixon; Susan N Thomas
Journal:  Adv Healthc Mater       Date:  2015-05-04       Impact factor: 9.933

3.  Structured triglyceride vehicles for oral delivery of halofantrine: examination of intestinal lymphatic transport and bioavailability in conscious rats.

Authors:  René Holm; Christopher J H Porter; Anette Müllertz; Henning G Kristensen; William N Charman
Journal:  Pharm Res       Date:  2002-09       Impact factor: 4.200

4.  Lipid-calcium phosphate nanoparticles for delivery to the lymphatic system and SPECT/CT imaging of lymph node metastases.

Authors:  Yu-Cheng Tseng; Zhenghong Xu; Kevin Guley; Hong Yuan; Leaf Huang
Journal:  Biomaterials       Date:  2014-03-06       Impact factor: 12.479

5.  Lymphatic trafficking kinetics and near-infrared imaging using star polymer architectures with controlled anionic character.

Authors:  Taryn R Bagby; Shaofeng Duan; Shuang Cai; Qiuhong Yang; Sharadvi Thati; Cory Berkland; Daniel J Aires; M Laird Forrest
Journal:  Eur J Pharm Sci       Date:  2012-04-22       Impact factor: 4.384

Review 6.  Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives.

Authors:  Melike Uner; Gülgün Yener
Journal:  Int J Nanomedicine       Date:  2007

7.  Intestinal lymphatic transport of halofantrine occurs after oral administration of a unit-dose lipid-based formulation to fasted dogs.

Authors:  Shui-Mei Khoo; David M Shackleford; Christopher J H Porter; Glenn A Edwards; William N Charman
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

8.  Structure-activity relationship of reversibly lipidized peptides: studies of fatty acid-desmopressin conjugates.

Authors:  Jeff Wang; Daphne Wu; Wei-Chiang Shen
Journal:  Pharm Res       Date:  2002-05       Impact factor: 4.200

Review 9.  Advanced drug delivery to the lymphatic system: lipid-based nanoformulations.

Authors:  Arshad Ali Khan; Jahanzeb Mudassir; Noratiqah Mohtar; Yusrida Darwis
Journal:  Int J Nanomedicine       Date:  2013-07-26

10.  Impact of molecular weight on lymphatic drainage of a biopolymer-based imaging agent.

Authors:  Taryn R Bagby; Shuang Cai; Shaofeng Duan; Sharadvi Thati; Daniel J Aires; Laird Forrest
Journal:  Pharmaceutics       Date:  2012-05-23       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.